Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
PORTABLE BIOCONTAINMENT UNITS (PBCUS) - EBOLA RESPONSE 2026Department of Health and Human Services$299.6K obligationsEnds Jun 4, 2027
DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAMDepartment of Health and Human Services$787.7K obligationsEnds Oct 30, 2026
THIS TASK ORDER IS TO PROVIDE REGULATORY SUPPORT FOR VAGINITIS PCR ASSAY.Department of Health and Human Services$369.2K obligationsEnds Jun 1, 2027
NINDS' DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP): SHAMLOO-SELECTIVE CB2 AGONIST; MRI RESEARCH INC:1186811 [26-000042]Department of Health and Human Services$1.4M obligationsEnds Aug 14, 2030
PERFORMING FDA 510K ENABLING STUDIES FOR A DIAGNOSTIC TO DETECT CIPROFLOXICIN RESISTANCE OR SUSCEPTABILITYDepartment of Health and Human Services$1.6M obligationsEnds Mar 10, 2027
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIESDepartment of Health and Human Services$149.7K obligationsEnds Jul 19, 2027
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSISDepartment of Health and Human Services$1.0M obligationsEnds Sep 29, 2026
REGULATORY SUPPORT FOR SOFTWARE AS MEDICAL DEVICE (SAMD) FOR NEXT-GEN SEQUENCING ID ANALYSISDepartment of Health and Human Services$7.2K obligationsEnds Mar 23, 2026
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)Department of Health and Human Services$5.2M obligationsEnds Nov 16, 2026
PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER 01. DAP-NCAP-00000009Department of Health and Human Services$382.8K obligationsEnds Jan 19, 2028
PHASE 1 SINGLE ASCENDING DOSE PHARMACOKINETICS STUDY: PARENT/METABOLITE(S). ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT. JULY 20, 2026 - JANUARY 19, 2028. TASK ORDER…Department of Health and Human Services$478.1K obligationsEnds Jan 19, 2028
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NTPDepartment of Health and Human Services$52.4M obligationsEnds Jan 17, 2027
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORTDepartment of Health and Human Services$21.3M obligationsEnds Jun 30, 2027
MRI GLOBAL - MILLER DMFPDepartment of Health and Human Services$2.4M obligationsEnds Jan 31, 2027
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)Department of Health and Human Services$514.9K obligationsEnds Jan 14, 2025
ML-246 (METARRESTIN) STABILITY STUDIESDepartment of Health and Human Services$131.9K obligationsEnds Jun 2, 2026
MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINEDepartment of Health and Human Services$3.5M obligationsEnds Sep 21, 2027
MANUFACTURE OF PLASMID DNA DRUG SUBSTANCE AND DRUG PRODUCTDepartment of Health and Human Services$2.8M obligationsEnds Apr 30, 2028
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPINGDepartment of Health and Human Services$2.2M obligationsEnds Nov 30, 2026
SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680)Department of Health and Human Services$2.1M obligationsEnds Sep 18, 2029
EVALUATION OF SHELF-LIFE OF SAMPLES OF INVESTIGATIONAL CLINICAL DRUG FORMULATIONS, TO INCLUDE PARENTERAL, ORAL, AND OTHER TYPES OF DOSAGE FORMS.Department of Health and Human Services$949.3K obligationsEnds Jan 31, 2026
IDP PRODUCTION FOR THE KETAMINE PROGRAM-QUOTE # NIH-OLAO 0001Department of Health and Human Services$2.3M obligationsEnds Feb 18, 2025
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORTDepartment of Health and Human Services$17.2M obligationsEnds Jun 30, 2023
DRUG SHELF LIFE TESTINGDepartment of Health and Human Services$1.7M obligationsEnds Jul 31, 2023
THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE…Department of Health and Human Services$1.9M obligationsEnds Sep 17, 2026